Close

Spectrum Pharma (SPPI) Misses Q1 EPS by 9c

May 2, 2017 4:27 PM EDT

Spectrum Pharma (NASDAQ: SPPI) reported Q1 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $29.1 million versus the consensus estimate of $32.23 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings